APO Research
Talk to an analyst

APO RESEARCH · REPORT

TNF Inhibitors for the Treatment of Plaque Psoriasis

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Growth and Trends Forecast to 2032

27 December 2025116 pages

Choose your research edition.

Industry ResearchTNF Inhibitors for the Treatment of Plaque Psoriasis Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal TNF Inhibitors for the Treatment of Plaque Psoriasis Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal TNF Inhibitors for the Treatment of Plaque Psoriasis Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global TNF Inhibitors for the Treatment of Plaque Psoriasis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for TNF Inhibitors for the Treatment of Plaque Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for TNF Inhibitors for the Treatment of Plaque Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for TNF Inhibitors for the Treatment of Plaque Psoriasis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of TNF Inhibitors for the Treatment of Plaque Psoriasis include Chia Tai Tianqing Pharmaceutical, Innovent Biologics, Sino Cell Technologies, Samsung Bioepis, Hangzhou Bozhirui Biopharmaceuticals, Hisun Pharmaceuticals, Bio-Thera Solutions, YL Biologics and UCB, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global TNF Inhibitors for the Treatment of Plaque Psoriasis market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The TNF Inhibitors for the Treatment of Plaque Psoriasis market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global TNF Inhibitors for the Treatment of Plaque Psoriasis market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to TNF Inhibitors for the Treatment of Plaque Psoriasis.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global TNF Inhibitors for the Treatment of Plaque Psoriasis market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Company

Chia Tai Tianqing Pharmaceutical

Innovent Biologics

Sino Cell Technologies

Samsung Bioepis

Hangzhou Bozhirui Biopharmaceuticals

Hisun Pharmaceuticals

Bio-Thera Solutions

YL Biologics

UCB

Teva

Sandoz

Pfizer

Janssen Biotech

Coherus BioSciences

Celltrion

Boehringer Ingelheim Pharmaceuticals

Biocon Biologics

Amgen

AbbVie

TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Type

Adalimumab

Certolizumab pegol

Etanercept

Infliximab

Other

TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

TNF Inhibitors for the Treatment of Plaque Psoriasis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TNF Inhibitors for the Treatment of Plaque Psoriasis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of TNF Inhibitors for the Treatment of Plaque Psoriasis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TNF Inhibitors for the Treatment of Plaque Psoriasis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of TNF Inhibitors for the Treatment of Plaque Psoriasis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of TNF Inhibitors for the Treatment of Plaque Psoriasis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Adalimumab Table 2. Major Company of Certolizumab pegol Table 3. Major Company of Etanercept Table 4. Major Company of Infliximab Table 5. Major Company of Other Table 6. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 8. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type (2021-2026) Table 9. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 10. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type (2021-2026) Table 11. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Price by Type (2021-2026) & (US$/Unit) Table 12. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2027-2032) & (K Units) Table 13. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type (2027-2032) Table 14. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2027-2032) & (US$ Million) Table 15. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type (2027-2032) Table 16. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Price by Type (2027-2032) & (US$/Unit) Table 17. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 18. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 19. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 20. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 24. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Type (2021-2026) & (US$ Million) Table 27. TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Trends Table 28. TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Drivers Table 29. TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Opportunities and Challenges Table 30. TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Restraints Table 31. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Revenue Market Share by Company (2021-2026) Table 33. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Company (2021-2026) & (K Units) Table 34. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Company (2021-2026) Table 35. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Major Company Production Sites and Headquarters Table 38. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company, Product Type & Application Table 39. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global TNF Inhibitors for the Treatment of Plaque Psoriasis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Region (2021-2026) & (K Units) Table 44. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Region (2021-2026) Table 45. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Region (2021-2026) & (US$ Million) Table 46. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Region (2021-2026) Table 47. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Region (2027-2032) & (K Units) Table 49. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Region (2027-2032) Table 50. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Region (2027-2032) & (US$ Million) Table 51. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Region (2027-2032) Table 52. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 55. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application (2021-2026) Table 56. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 57. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application (2021-2026) Table 58. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Price by Application (2021-2026) & (US$/Unit) Table 59. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2027-2032) & (K Units) Table 60. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application (2027-2032) Table 61. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2027-2032) & (US$ Million) Table 62. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application (2027-2032) Table 63. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Price by Application (2027-2032) & (US$/Unit) Table 64. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 65. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 66. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 67. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 71. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Application (2021-2026) & (US$ Million) Table 74. Chia Tai Tianqing Pharmaceutical Company Information Table 75. Chia Tai Tianqing Pharmaceutical Business Overview Table 76. Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 78. Chia Tai Tianqing Pharmaceutical Recent Development Table 79. Innovent Biologics Company Information Table 80. Innovent Biologics Business Overview Table 81. Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 83. Innovent Biologics Recent Development Table 84. Sino Cell Technologies Company Information Table 85. Sino Cell Technologies Business Overview Table 86. Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 88. Sino Cell Technologies Recent Development Table 89. Samsung Bioepis Company Information Table 90. Samsung Bioepis Business Overview Table 91. Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 93. Samsung Bioepis Recent Development Table 94. Hangzhou Bozhirui Biopharmaceuticals Company Information Table 95. Hangzhou Bozhirui Biopharmaceuticals Business Overview Table 96. Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 98. Hangzhou Bozhirui Biopharmaceuticals Recent Development Table 99. Hisun Pharmaceuticals Company Information Table 100. Hisun Pharmaceuticals Business Overview Table 101. Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 103. Hisun Pharmaceuticals Recent Development Table 104. Bio-Thera Solutions Company Information Table 105. Bio-Thera Solutions Business Overview Table 106. Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 108. Bio-Thera Solutions Recent Development Table 109. YL Biologics Company Information Table 110. YL Biologics Business Overview Table 111. YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 113. YL Biologics Recent Development Table 114. UCB Company Information Table 115. UCB Business Overview Table 116. UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 118. UCB Recent Development Table 119. Teva Company Information Table 120. Teva Business Overview Table 121. Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 123. Teva Recent Development Table 124. Sandoz Company Information Table 125. Sandoz Business Overview Table 126. Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 128. Sandoz Recent Development Table 129. Pfizer Company Information Table 130. Pfizer Business Overview Table 131. Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 133. Pfizer Recent Development Table 134. Janssen Biotech Company Information Table 135. Janssen Biotech Business Overview Table 136. Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 138. Janssen Biotech Recent Development Table 139. Coherus BioSciences Company Information Table 140. Coherus BioSciences Business Overview Table 141. Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 143. Coherus BioSciences Recent Development Table 144. Celltrion Company Information Table 145. Celltrion Business Overview Table 146. Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 148. Celltrion Recent Development Table 149. Boehringer Ingelheim Pharmaceuticals Company Information Table 150. Boehringer Ingelheim Pharmaceuticals Business Overview Table 151. Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 152. Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 153. Boehringer Ingelheim Pharmaceuticals Recent Development Table 154. Biocon Biologics Company Information Table 155. Biocon Biologics Business Overview Table 156. Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 157. Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 158. Biocon Biologics Recent Development Table 159. Amgen Company Information Table 160. Amgen Business Overview Table 161. Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 162. Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 163. Amgen Recent Development Table 164. AbbVie Company Information Table 165. AbbVie Business Overview Table 166. AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 167. AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio Table 168. AbbVie Recent Development Table 169. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026) & (K Units) Table 171. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share by Country (2021-2026) Table 172. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 173. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 174. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 176. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country (2021-2026) Table 177. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share Forecast by Country (2027-2032) Table 179. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026) & (K Units) Table 181. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share by Country (2021-2026) Table 182. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 183. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 184. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 186. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country (2021-2026) Table 187. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share Forecast by Country (2027-2032) Table 189. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 190. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026) & (K Units) Table 191. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share by Country (2021-2026) Table 192. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 193. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 194. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 195. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 196. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country (2021-2026) Table 197. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 198. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share Forecast by Country (2027-2032) Table 199. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 200. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026) & (K Units) Table 201. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share by Country (2021-2026) Table 202. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 203. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 204. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 205. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 206. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country (2021-2026) Table 207. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 208. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share Forecast by Country (2027-2032) Table 209. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 210. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026) & (K Units) Table 211. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share by Country (2021-2026) Table 212. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032) & (K Units) Table 213. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share Forecast by Country (2027-2032) Table 214. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 215. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026) & (US$ Million) Table 216. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country (2021-2026) Table 217. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032) & (US$ Million) Table 218. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share Forecast by Country (2027-2032) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. TNF Inhibitors for the Treatment of Plaque Psoriasis Distributors List Table 222. TNF Inhibitors for the Treatment of Plaque Psoriasis Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. TNF Inhibitors for the Treatment of Plaque Psoriasis Image Figure 2. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size (2021-2032) & (US$ Million) Figure 4. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (2021-2032) & (K Units) Figure 5. Adalimumab Image Figure 6. Global Adalimumab Sales YoY Growth (2021-2032) & (K Units) Figure 7. Certolizumab pegol Image Figure 8. Global Certolizumab pegol Sales YoY Growth (2021-2032) & (K Units) Figure 9. Etanercept Image Figure 10. Global Etanercept Sales YoY Growth (2021-2032) & (K Units) Figure 11. Infliximab Image Figure 12. Global Infliximab Sales YoY Growth (2021-2032) & (K Units) Figure 13. Other Image Figure 14. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Type 2025 VS 2032 Figure 17. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type in 2025 Figure 18. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type in 2025 Figure 19. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type in 2025 Figure 20. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type in 2025 Figure 23. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type in 2025 Figure 24. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 TNF Inhibitors for the Treatment of Plaque Psoriasis Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospital and Clinic Image Figure 30. Global Hospital and Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Application 2025 VS 2032 Figure 37. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application in 2025 Figure 38. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application in 2025 Figure 39. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application in 2025 Figure 40. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application in 2025 Figure 43. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application in 2025 Figure 44. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Market Share in Value by Application in 2025 Figure 47. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. TNF Inhibitors for the Treatment of Plaque Psoriasis Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. TNF Inhibitors for the Treatment of Plaque Psoriasis Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Adalimumab
  • Certolizumab pegol
  • Etanercept
  • Infliximab
  • Other
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Innovent Biologics
  • Sino Cell Technologies
  • Samsung Bioepis
  • Hangzhou Bozhirui Biopharmaceuticals
  • Hisun Pharmaceuticals
  • Bio-Thera Solutions
  • YL Biologics
  • UCB
  • Teva
  • Sandoz
  • Pfizer
  • Janssen Biotech
  • Coherus BioSciences
  • Celltrion
  • Boehringer Ingelheim Pharmaceuticals
  • Biocon Biologics
  • Amgen
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Estimates and Forecasts (2021-2032)
  5. 1.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Type
  6. 1.3.1 Adalimumab
  7. 1.3.2 Certolizumab pegol
  8. 1.3.3 Etanercept
  9. 1.3.4 Infliximab
  10. 1.3.5 Other
  11. 1.4 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Type
  12. 1.4.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Trends
  2. 2.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Drivers
  3. 2.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Opportunities and Challenges
  4. 2.4 TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Revenue (2021-2026)
  2. 3.2 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (2021-2026)
  3. 3.3 Global Top Players by TNF Inhibitors for the Treatment of Plaque Psoriasis Price (2021-2026)
  4. 3.4 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Major Company Production Sites & Headquarters
  6. 3.6 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company, Product Type & Application
  7. 3.7 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 TNF Inhibitors for the Treatment of Plaque Psoriasis Players Market Share by Revenue in 2025
  11. 3.8.3 2025 TNF Inhibitors for the Treatment of Plaque Psoriasis Tier 1, Tier 2, and Tier 3
4 TNF Inhibitors for the Treatment of Plaque Psoriasis Regional Status and Outlook
  1. 4.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size by Region
  3. 4.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Value by Region (2021-2026)
  5. 4.2.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Region
  7. 4.3.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales in Value by Region (2027-2032)
  9. 4.3.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 TNF Inhibitors for the Treatment of Plaque Psoriasis by Application
  1. 5.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Market by Application
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Application
  6. 5.2.1 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global TNF Inhibitors for the Treatment of Plaque Psoriasis Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 6.2 Innovent Biologics
  8. 6.2.1 Innovent Biologics Company Information
  9. 6.2.2 Innovent Biologics Business Overview
  10. 6.2.3 Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Innovent Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  12. 6.2.5 Innovent Biologics Recent Developments
  13. 6.3 Sino Cell Technologies
  14. 6.3.1 Sino Cell Technologies Company Information
  15. 6.3.2 Sino Cell Technologies Business Overview
  16. 6.3.3 Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sino Cell Technologies TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  18. 6.3.5 Sino Cell Technologies Recent Developments
  19. 6.4 Samsung Bioepis
  20. 6.4.1 Samsung Bioepis Company Information
  21. 6.4.2 Samsung Bioepis Business Overview
  22. 6.4.3 Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Samsung Bioepis TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  24. 6.4.5 Samsung Bioepis Recent Developments
  25. 6.5 Hangzhou Bozhirui Biopharmaceuticals
  26. 6.5.1 Hangzhou Bozhirui Biopharmaceuticals Company Information
  27. 6.5.2 Hangzhou Bozhirui Biopharmaceuticals Business Overview
  28. 6.5.3 Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Hangzhou Bozhirui Biopharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  30. 6.5.5 Hangzhou Bozhirui Biopharmaceuticals Recent Developments
  31. 6.6 Hisun Pharmaceuticals
  32. 6.6.1 Hisun Pharmaceuticals Company Information
  33. 6.6.2 Hisun Pharmaceuticals Business Overview
  34. 6.6.3 Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hisun Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  36. 6.6.5 Hisun Pharmaceuticals Recent Developments
  37. 6.7 Bio-Thera Solutions
  38. 6.7.1 Bio-Thera Solutions Company Information
  39. 6.7.2 Bio-Thera Solutions Business Overview
  40. 6.7.3 Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Thera Solutions TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  42. 6.7.5 Bio-Thera Solutions Recent Developments
  43. 6.8 YL Biologics
  44. 6.8.1 YL Biologics Company Information
  45. 6.8.2 YL Biologics Business Overview
  46. 6.8.3 YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 YL Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  48. 6.8.5 YL Biologics Recent Developments
  49. 6.9 UCB
  50. 6.9.1 UCB Company Information
  51. 6.9.2 UCB Business Overview
  52. 6.9.3 UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 UCB TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  54. 6.9.5 UCB Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  60. 6.10.5 Teva Recent Developments
  61. 6.11 Sandoz
  62. 6.11.1 Sandoz Company Information
  63. 6.11.2 Sandoz Business Overview
  64. 6.11.3 Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sandoz TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  66. 6.11.5 Sandoz Recent Developments
  67. 6.12 Pfizer
  68. 6.12.1 Pfizer Company Information
  69. 6.12.2 Pfizer Business Overview
  70. 6.12.3 Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Pfizer TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  72. 6.12.5 Pfizer Recent Developments
  73. 6.13 Janssen Biotech
  74. 6.13.1 Janssen Biotech Company Information
  75. 6.13.2 Janssen Biotech Business Overview
  76. 6.13.3 Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Janssen Biotech TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  78. 6.13.5 Janssen Biotech Recent Developments
  79. 6.14 Coherus BioSciences
  80. 6.14.1 Coherus BioSciences Company Information
  81. 6.14.2 Coherus BioSciences Business Overview
  82. 6.14.3 Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Coherus BioSciences TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  84. 6.14.5 Coherus BioSciences Recent Developments
  85. 6.15 Celltrion
  86. 6.15.1 Celltrion Company Information
  87. 6.15.2 Celltrion Business Overview
  88. 6.15.3 Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Celltrion TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  90. 6.15.5 Celltrion Recent Developments
  91. 6.16 Boehringer Ingelheim Pharmaceuticals
  92. 6.16.1 Boehringer Ingelheim Pharmaceuticals Company Information
  93. 6.16.2 Boehringer Ingelheim Pharmaceuticals Business Overview
  94. 6.16.3 Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Boehringer Ingelheim Pharmaceuticals TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  96. 6.16.5 Boehringer Ingelheim Pharmaceuticals Recent Developments
  97. 6.17 Biocon Biologics
  98. 6.17.1 Biocon Biologics Company Information
  99. 6.17.2 Biocon Biologics Business Overview
  100. 6.17.3 Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Biocon Biologics TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  102. 6.17.5 Biocon Biologics Recent Developments
  103. 6.18 Amgen
  104. 6.18.1 Amgen Company Information
  105. 6.18.2 Amgen Business Overview
  106. 6.18.3 Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Amgen TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  108. 6.18.5 Amgen Recent Developments
  109. 6.19 AbbVie
  110. 6.19.1 AbbVie Company Information
  111. 6.19.2 AbbVie Business Overview
  112. 6.19.3 AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 AbbVie TNF Inhibitors for the Treatment of Plaque Psoriasis Product Portfolio
  114. 6.19.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
  2. 7.1.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026)
  4. 7.1.3 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032)
  5. 7.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
  6. 7.2.1 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026)
  8. 7.2.3 North America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
  2. 8.1.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026)
  4. 8.1.3 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032)
  5. 8.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
  6. 8.2.1 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026)
  8. 8.2.3 Europe TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
  2. 9.1.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
  6. 9.2.1 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
  2. 10.1.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026)
  4. 10.1.3 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032)
  5. 10.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
  6. 10.2.1 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026)
  8. 10.2.3 South America TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country
  2. 11.1.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country
  6. 11.2.1 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa TNF Inhibitors for the Treatment of Plaque Psoriasis Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Value Chain Analysis
  2. 12.1.1 TNF Inhibitors for the Treatment of Plaque Psoriasis Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 TNF Inhibitors for the Treatment of Plaque Psoriasis Production Mode & Process
  7. 12.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 TNF Inhibitors for the Treatment of Plaque Psoriasis Distributors
  10. 12.2.3 TNF Inhibitors for the Treatment of Plaque Psoriasis Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst